Homehealthcare investment

healthcare investment

Pfizer (PFE) RSV Vaccine Candidate BLA Gets FDA’s Priority Tag

Pfizer (PFE) RSV Vaccine Candidate BLA Gets FDA’s Priority Tag

December 8, 2022

Esperion (ESPR) Reports Positive Data From CLEAR Study

Esperion (ESPR) Reports Positive Data From CLEAR Study

December 8, 2022

Gilead Sciences: U.S. Military Veteran Battles Lymphoma With Car T-Cell Therapy: Marcus’ Story

Gilead Sciences: U.S. Military Veteran Battles Lymphoma With Car T-Cell Therapy: Marcus’ Story

December 8, 2022

Zacks Investment Ideas feature highlights: ATAI Life Sciences, Biogen and Sage

Zacks Investment Ideas feature highlights: ATAI Life Sciences, Biogen and Sage

December 8, 2022

Why Is Amicus Therapeutics (FOLD) Up 13.7% Since Last Earnings Report?

Why Is Amicus Therapeutics (FOLD) Up 13.7% Since Last Earnings Report?

December 7, 2022

Emergent (EBS) OTC Narcan Filing Gets FDA Priority Review Tag

Emergent (EBS) OTC Narcan Filing Gets FDA Priority Review Tag

December 7, 2022

Mirati (MRTX) Down After 1st-Line Lung Cancer Data on Adagrasib

Mirati (MRTX) Down After 1st-Line Lung Cancer Data on Adagrasib

December 7, 2022

Biogen (BIIB), Sage Finish Zuranolone NDA Filing for Depression

Biogen (BIIB), Sage Finish Zuranolone NDA Filing for Depression

December 7, 2022

Wall Street Bulls Look Optimistic About Gilead (GILD): Should You Buy?

Wall Street Bulls Look Optimistic About Gilead (GILD): Should You Buy?

December 7, 2022

The Zacks Analyst Blog Highlights Exxon Mobil, WesBanco, S&T Bancorp, Gilead Sciences and Conagra Brands

The Zacks Analyst Blog Highlights Exxon Mobil, WesBanco, S&T Bancorp, Gilead Sciences and Conagra Brands

December 7, 2022

« 1 … 13 14 15 16 17 … 449 »